Avadel Pharmaceuticals
AVDL
$17.81
Share price
-0.06%
Change (1 day)
69.94%
Change (1 year)
Categories
Avadel Pharmaceuticals (AVDL) - P/B ratio
P/B ratio as of April 2024 : 18.4
According to Avadel Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 18.4.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Avadel Pharmaceuticals - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 14.5 | -169.09% |
| 2022-12-31 | -20.9 | -445.57% |
| 2021-12-31 | 6.05 | 152.34% |
| 2020-12-31 | 2.40 | -124.77% |
| 2019-12-31 | -9.68 | -128.19% |
| 2018-12-31 | 34.3 | 801.58% |
| 2017-12-31 | 3.81 | -62.6% |
| 2016-12-31 | 10.2 | 39.84% |
| 2015-12-31 | 7.28 | -73.66% |
| 2014-12-31 | 27.7 | -227.59% |
| 2013-12-31 | -21.7 | -974.19% |
| 2012-12-31 | 2.48 | -43.2% |
| 2011-12-31 | 4.37 | -5.99% |
| 2010-12-31 | 4.64 | 15.64% |
| 2009-12-31 | 4.02 | 105.43% |
| 2008-12-31 | 1.95 | -55.52% |
| 2007-12-31 | 4.39 | -55.34% |
| 2006-12-31 | 9.84 | 90.49% |
| 2005-12-31 | 5.17 | 42.25% |
| 2004-12-31 | 3.63 | -41.67% |
| 2003-12-31 | 6.23 | 8.55% |
| 2002-12-31 | 5.73 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6322 | -96.56% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.44 | -92.17% | 🇺🇸 USA |